Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry represents a **pseudogene** similar to the ribosomal protein S15a gene, meaning it is a DNA sequence that was derived from the functional RPS15A gene but has accumulated mutations (such as frameshifts or stop codons) rendering it *incapable of producing a functional protein product*[2][5]. Pseudogenes are typically classified as “processed” if they arose via retrotransposition, or “non-processed” if they arose from duplication followed by mutation[2][5][8]. While pseudogenes are common in the human genome and generally considered nonfunctional, a minority have regulatory roles at the RNA level, such as acting as competitive endogenous RNAs in cancer, but there is no evidence that this specific pseudogene (ENSG00000235182) plays a direct biological or therapeutic role[9]. In summary, ENSG00000235182 is a **non-functional pseudogene** similar to ribosomal protein S15a. It is not a valid therapeutic or research target, does not encode a protein, and is mainly of genomic interest rather than clinical or pharmacological relevance[2][5][6].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S15a pseudogene.